Elute Earns FDA 510(k) for BonVie Bone Void Filler
BonVie+ is a calcium-salt resorbable bone void filler used to fill bone defects that is, with time, replaced by new...
Mar 12, 2025,
Elute Earns FDA 510(k) for BonVie Bone Void Filler
Investment Firms Win Bid for Exactech
A group of investors has been designated as the winning bidder to acquire substantially all of Exactech's assets. ...
Mar 11, 2025,
Study Compares Symmetrical vs. Asymmetrical Designs in TKA
Findings build on evidence that Total Joint Orthopedics' Klassic Knee’s universal femoral design reduces the OR footprint and improves overall...
Mar 11, 2025,
OsteoCentric Technologies Enters Licensing Agreement with Globus Medical
OsteoCentric's MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the first implant-to-bone interface to support primary implant stability...
Mar 11, 2025,
Pixee Medical Launching Knee+ NexSight in the US
Knee+ NexSight allows real-time navigation without setups or intraoperative instrument calibration, allowing surgeons to focus on the patient....
Mar 11, 2025,
Zydus Lifesciences Acquires Majority Stake in Amplitude Surgical
Amplitude Surgical develops and markets orthopedic implants, covering the main pathologies affecting the hip and knee. ...
Mar 11, 2025,
Interim Analysis of 1-level BAGUERA-C IDE Study
Interim results indicate that the cervical disc prosthesis met the threshold for a non-inferiority claim against the study control....
Mar 11, 2025,
11 Mar The State of Enabling Technology in 2025
We expect healthy demand, more competitive pressure at the top of the market and a focus on creating optionality within...
FDA Approves Expanded Use of Miach Orthopaedics’ BEAR Implant
The BEAR Implant is now cleared to treat torn ACLs in children and adolescents of any age, as well as...
Mar 10, 2025,
Tetrous Closes $6.5 Million Series A
Proceeds will be used to increase the company's market penetration and develop further clinical data in support of the EnFix...
Mar 10, 2025,
Loading new posts...
No more posts
Contact Us
0